NBIX - Neurocrine Biosciences - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

NBIX is currently covered by 22 analysts with an average price target of $150.05. This is a potential upside of $16.39 (12.26%) from yesterday's end of day stock price of $133.66.

Neurocrine Biosciences's activity chart (see below) currently has 239 price targets and 216 ratings on display. The stock rating distribution of NBIX is 51.22% BUY, 47.56% HOLD and 1.22% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.13% with an average time for these price targets to be met of 238.16 days.

Highest price target for NBIX is $200, Lowest price target is $100, average price target is $150.05.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 13-Mar-2024.

Currently out of the existing stock ratings of NBIX, 42 are a BUY (51.22%), 39 are a HOLD (47.56%), 1 are a SELL (1.22%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

200

$60.56 (43.43%)

165

1 months 10 days ago

14/22 (63.64%)

$58.2 (41.04%)

332

Buy

148

$8.56 (6.14%)

134

2 months ago

14/15 (93.33%)

$13.82 (10.30%)

344

Hold

140

$0.56 (0.40%)

127

2 months 15 days ago

2/2 (100%)

$5.58 (4.15%)

22

Hold

140

$0.56 (0.40%)

127

2 months 15 days ago

5/5 (100%)

$5.58 (4.15%)

57

Hold

140

$0.56 (0.40%)

114

2 months 15 days ago

9/9 (100%)

$5.58 (4.15%)

66

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NBIX (Neurocrine Biosciences) average time for price targets to be met?

On average it took 238.16 days on average for the stock forecasts to be realized with a an average price target met ratio 85.13

Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?

Andrew Fein has 15 price targets and 11 ratings on NBIX

Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?

Jay Olson with highest potential upside - $60.56

Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?

Thomas Wei with lowest potential downside - -$69.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?